Sri Harsha Tella (S H Tella)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Metastatic Colorectal Cancer

Affordable Care Act

Top Venues

Leukemia & lymphoma

Diabetes/metabolism research and reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Harrison Storandt, Sri Harsha Tella, Mikolaj A Wieczorek, David Hodge, Julia K Elrod, Philip S Rosenberg, Zhaohui Jin, Amit Mahipal
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States. Cancers 16 (4) (2024)
Michael Harrison Storandt, Sri Harsha Tella, Mikolaj A Wieczorek, David Hodge, Julia K Elrod, Philip S Rosenberg, Zhaohui Jin, Amit Mahipal
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States. Cancers 16 (4) (2024)
Sri Harsha Tella, Nathan Foster, Qian Shi, Tran Nguyen, Mitesh J Borad, Robert R McWilliams, Steven R Alberts, Wen Wee Ma, Sakti Chakrabarti, Briant Fruth, Jaclynn Wessling, Mindy Hartgers, Leslie Washburn, Martin E Fernandez-Zapico, Tara L Hogenson, Henry Pitot, Zhaohui Jin, Amit Mahipal
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma. The oncologist (2023)
Michael Harrison Storandt, Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, Zhaohui Jin
Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations. Journal of hepatocellular carcinoma 9 (2022)
Sri Harsha Tella, Amit Mahipal
An evaluation of ivosidenib for the treatment of IDH1 -mutant cholangiocarcinoma. Expert opinion on pharmacotherapy 23 (17) (2022)
Sergiy V Kushchayev, Yevgeniya S Kushchayeva, Sri Harsha Tella, Tetiana Glushko, Karel Pacak, Oleg M Teytelboym
Medullary Thyroid Carcinoma: An Update on Imaging. Journal of thyroid research 2019 (2019)
Y S Kushchayeva, Sri Harsha Tella, S V Kushchayev, D Van Nostrand, K Kulkarni
Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and 123I for localization of rapid washout parathyroid adenomas. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 30 (5) (2019)
Brian Chen, Sumimasa Nagai, James O Armitage, Bartlett Witherspoon, Chadi Nabhan, Ashley C Godwin, Y Tony Yang, Anuhya Kommalapati, Sri Harsha Tella, Carlo DeAngelis, Dennis W Raisch, Oliver Sartor, William J Hrushesky, Paul S Ray, Paul R Yarnold, Bryan L Love, LeAnn B Norris, Kevin Knopf, Laura Bobolts, Joshua Riente, Stefano Luminari, Robert C Kane, Shamia Hoque, Charles L Bennett
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. The oncologist 24 (4) (2019)
Anuhya Kommalapati, Yevgeniya Kushchayeva, Sri Harsha Tella
Incidence, racial disparities and survival outcomes of mast cell malignancies: analysis from a national database. Leukemia & lymphoma 59 (9) (2018)
Amit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, Alexander Lim, Richard Kim
Novel targeted treatment options for advanced cholangiocarcinoma. Expert opinion on investigational drugs 27 (9) (2018)
Anuhya Kommalapati, Sri Harsha Tella, Ronald S Go, Gaurav Goyal
Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma. Leukemia & lymphoma 60 (2) (2018)
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data. Diabetes/metabolism research and reviews 33 (8) (2017)
Anuhya Kommalapati, Sri Harsha Tella, Martin Durkin, Ronald S Go, Gaurav Goyal
Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood 131 (2) (2017)